Statera Biopharma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STAB research report →
About the company
Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge immunotherapies. These novel treatments aim to address a range of serious conditions, including autoimmune disorders, neutropenia, anemia, emerging viral infections, and various cancers.
- CEO
- Blake Hawley
- IPO
- 2021
- Employees
- 46
- HQ
- Fort Collins, CO, US
Price Chart
- Market Cap
- $7.14K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 6677.48%
- ROIC
- -666.54%
- Revenue
- $0 · 0.00%
- Net Income
- $-174,408,164 · -1218.82%
- EPS
- $-4.97 · -855.77%
- Op Income
- $-98,343,803
- FCF YoY
- -457.30%
- 52W High
- $0.03
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -4.78
- Avg Volume
- 4.10K
Get TickerSpark's AI analysis on STAB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 22, 22 | Chandrasekhar Satishchandran | other | 0 |
| Sep 9, 21 | SALUCK RANDY S. | other | 60,000 |
| Sep 9, 21 | Barbarick Steve K | other | 60,000 |
| Sep 9, 21 | Verny Lea | other | 60,000 |
| Sep 28, 21 | Markvicka Taunia | other | 100,000 |
| Jul 27, 21 | Handley Michael K | other | 296,609 |
| Jul 27, 21 | Handley Michael K | other | 0 |
| Jul 27, 21 | Buckheit Robert | other | 24,378 |
| Jul 27, 21 | Selsky Clifford | other | 101,579 |
| Jul 27, 21 | McAvoy Cozette M. | other | 60,947 |
Our STAB coverage
Recent articles, reports, and earnings notes.
No research on STAB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate STAB report →Similar companies
Peers in the same neighborhood.